Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
- Resource Type
- Article
- Source
- Lancet Respiratory Medicine; Nov2023, Vol. 11 Issue 11, p975-990, 16p
- Subject
RECOMBINANT proteins NUCLEIC acid amplification techniques BELL'S palsy SARS-CoV-2 Omicron variant PERICARDITIS SARS-CoV-2 - Language
- ISSN
- 22132600